Biofrontera Group - Similar companies

We find the nearest competitors to any company through our proprietary AI and database of millions of companies

Biofrontera Group

Pharmaceuticals · Leverkusen, Nordrhein-Westfalen
Website: biofrontera.com

Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical co ... smetics. The Germany-based company, with over 150 employees worldwide, develops and markets innovative products for the care, protection and treatment of the skin. The company’s lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz® has been marketed in the EU since 2012 and in the United States since May 2016. In addition, the company markets the prescription medication Xepi™ for the treatment of impetigo in the United States. In the EU, the company also sells the dermocosmetics series Belixos®, which offers specialized care for damaged or diseased skin. Biofrontera is the first German founder-led pharmaceutical company to receive a centralized European and a US approval for a drug developed in-house. The Biofrontera Group was founded in 1997 by the current CEO Prof. Dr. Hermann Lübbert and is listed on the Frankfurt Stock Exchange (ticker symbol: B8F) and on the US NASDAQ (ticker symbol: BFRA). read more

Competitor Description Similarity

Loading..